Hopman Mark sold BBNX
September 4, 2025 · Form 4 insider transaction
Hopman Mark sold 6,818 shares of Beta Bionics, Inc. at $19.97 per share, a transaction worth $136.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,818
Price
$19.97
Total value
$136.2K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 4, 2025
Filing dateSeptember 8, 2025
Shares owned after31,215
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.; The weighted average sale price for the transaction reported was $19.9736 and the range of prices were between $19.43 and $20.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.